INS and type 2 diabetes mellitus: In another trial, the Restoring Insulin Secretion (RISE) study, interventions to improve or preserve β-cell function were compared across 91 adolescents (aged 10–19 years) and 132 adults (aged 20–65 years) with IGT or T2DM diagnosed within the previous 12 months [44].